| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |